Mid-South Cancer Center — Germantown, Tennessee

Mid-South Cancer Center is a clinical research site located in Germantown, Tennessee, United States 38138.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid-South Cancer Center has participated in 3 clinical trials.

Therapeutic areas: Prostate Cancer, NSCLC, Lung Cancer.

Sponsors: Agennix, CTI BioPharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-South Cancer Center?

Mid-South Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-South Cancer Center conducted?

Mid-South Cancer Center has 3 clinical trials on record. Their work covers Prostate Cancer, NSCLC, Lung Cancer.

Is Mid-South Cancer Center accredited by Crixeo Health?

Mid-South Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-South Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.